Abstract:2‐Arachidonoyl‐glycerol (2‐AG) is an endocannabinoid with anti‐inflammatory properties. Blocking 2‐AG hydrolysis to enhance CB 2 signaling has proven effective in mouse models of inflammation. However, the expression of 2‐AG lipases has never been thoroughly investigated in human leukocytes. Herein, we investigated the expression of seven 2‐AG hydrolases by human blood leukocytes and alveolar macrophages (AMs) and found the following protein expression pattern: monoacylglycerol (MAG lipase; eosinophils, AMs, monocytes), carboxylesterase (CES1; monocytes, AMs), palmitoyl‐protein thioesterase (PPT1; AMs), α/β‐hydrolase domain (ABHD6; mainly AMs), ABHD12 (all), ABHD16A (all), and LYPLA2 (lysophospholipase 2; monocytes, lymphocytes, AMs). We next found that all leukocytes could hydrolyze 2‐AG and its metabolites derived from cyclooxygenase‐2 (prostaglandin E 2 ‐glycerol [PGE 2 ‐G]) and the 15‐lipoxygenase (15‐hydroxy‐eicosatetraenoyl‐glycerol [15‐HETE‐G]). Neutrophils and eosinophils were consistently better at hydrolyzing 2‐AG and its metabolites than monocytes and lymphocytes. Moreover, the efficacy of leukocytes to hydrolyze 2‐AG and its metabolites was 2‐AG ≥ 15‐HETE‐G >> PGE 2 ‐G for each leukocyte. Using the inhibitors methylarachidonoyl‐fluorophosphonate (MAFP), 4‐nitrophenyl‐4‐(dibenzo[d][1,3]dioxol‐5‐yl(hydroxy)methyl)piperidine‐1‐carboxylate (JZL184), Palmostatin B, 4′‐carbamoylbiphenyl‐4‐yl methyl(3‐(pyridin‐4‐yl)benzyl)carbamate, N‐methyl‐N‐[[3‐(4‐pyridinyl)phenyl]methyl]‐4′‐(aminocarbonyl)[1,1′‐biphenyl]‐4‐yl ester carbamic acid (WWL70), 4′‐[[[methyl[[3‐(4‐pyridinyl)phenyl]methyl]amino]carbonyl]oxy]‐[1,1′‐biphenyl]‐4‐carboxylic acid, ethyl ester (WWL113), tetrahydrolipstatin, and ML349, we could not pinpoint a specific hydrolase responsible for the hydrolysis of 2‐AG, PGE 2 ‐G, and 15‐HETE‐G by these leukocytes. Furthermore, JZL184, a selective MAG lipase inhibitor, blocked the hydrolysis of 2‐AG, PGE 2 ‐G, and 15‐HETE‐G by neutrophils and the hydrolysis of PGE 2 ‐G and 15‐HETE‐G by lymphocytes, two cell types with limited/no MAG lipase. Using an activity‐based protein profiling (ABPP) probe to label hydrolases in leukocytes, we found that they express many MAFP‐sensitive hydrolases and an unknown JZL184‐sensitive hydrolase of ∼52 kDa. Altogether, our results indicate that human leukocytes are experts at hydrolyzing 2‐AG and its metabolites via multiple lipases and probably via a yet‐to‐be characterized 52 kDa hydrolase. Blocking 2‐AG hydrolysis in humans will likely abrogate the ability of human leukocytes to degrade 2‐AG and its metabolites and increase their anti‐inflammatory effects in vivo.

Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6

DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses

Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes

Temporal dissociation of COX-2-dependent arachidonic acid and 2-arachidonoylglycerol metabolism in RAW264.7 macrophages

The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors

Robust Hydrolysis of Prostaglandin Glycerol Esters by Human Monoacylglycerol Lipase (MAGL)

Inhibition of 2-arachidonoylglycerol degradation enhances glial immunity by single-cell transcriptomic analysis

Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver

A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature

ABHD6 suppression promotes anti-inflammatory polarization of adipose tissue macrophages via 2-monoacylglycerol/PPAR signaling in obese mice

The glycolysis inhibitor 2-deoxyglucose ameliorates adjuvant-induced arthritis by regulating macrophage polarization in an AMPK-dependent manner

Human leukocytes differentially express endocannabinoid‐glycerol lipases and hydrolyze 2‐arachidonoyl‐glycerol and its metabolites from the 15‐lipoxygenase and cyclooxygenase pathways

Mollugin Inhibits the Inflammatory Response in Lipopolysaccharide-Stimulated RAW264.7 Macrophages by Blocking the Janus Kinase-Signal Transducers and Activators of Transcription Signaling Pathway

ABHD6 Selectively Controls Metabotropic-Dependent Increases in 2-AG Production

Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling

Therapeutic potential of targeting α/β-Hydrolase domain-containing 6 (ABHD6)

Anti-Inflammatory Activity of Glycolipids and a Polyunsaturated Fatty Acid Methyl Ester Isolated from the Marine Dinoflagellate Karenia mikimotoi

Lipid Receptor G2A-Mediated Signal Pathway Plays a Critical Role in Inflammatory Response by Promoting Classical Macrophage Activation

Choline Glycerophospholipid-Derived Prostaglandins Attenuate TNFα Gene Expression in Macrophages via a cPLA2α/COX-1 Pathway

Prostaglandin E2 Boosts the Hyaluronan-Mediated Increase in Inflammatory Response to Lipopolysaccharide by Enhancing Lyve1 Expression

Release of Anti-Inflammatory Palmitoleic Acid and Its Positional Isomers by Mouse Peritoneal Macrophages